Ibuprofen Active Pharmaceutical Ingredient (Api) Market Size to grow by USD 26.3 million between 2024-2028
According to a research report “ Ibuprofen Active Pharmaceutical Ingredient (Api) Market” by End-user (Pharmaceutical companies, Contract manufacturing organizations) Product (Prescription, Over-the-counter) Geography (Asia, North America, Europe, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 26.3 million, at a CAGR of 2.08% during the forecast period. The global ibuprofen Active Pharmaceutical Ingredient (API) market is poised for growth due to the rising geriatric population and subsequent demand for chronic illness treatments. With age, the likelihood of acquiring comorbidities and conditions such as osteoarthritis increases, leading to a higher need for effective pain management solutions. According to the Centers for Disease Control and Prevention (CDC), the US population aged 65 and above is projected to double by 2030, reaching approximately 71 million, further fueling market expansion. This demographic shift presents significant opportunities for ibuprofen API manufacturers to cater to the escalating healthcare demands of the elderly population..
Browse market data tables, figures, and in-depth TOC on “Ibuprofen Active Pharmaceutical Ingredient (Api) Market” by End-user (Pharmaceutical companies, Contract manufacturing organizations) Product (Prescription, Over-the-counter) Geography (Asia, North America, Europe, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By End-user, the Pharmaceutical companies segment is projected to dominate the market size in 2024
Ibuprofen Active Pharmaceutical Ingredient (API) is a crucial component in over-the-counter and prescription medications, renowned for its potent analgesic and anti-inflammatory properties. The global Ibuprofen API market is witnessing significant growth, driven by increasing demand for pain relief and inflammation management products. Key players in this market focus on enhancing production capacity and improving product quality to cater to the burgeoning consumer base. Regulatory compliance and cost-effective manufacturing are critical challenges for market participants.
By Product, Prescription segment is expected to hold the largest market size for the year 2024
Ibuprofen Active Pharmaceutical Ingredient (API) is a crucial component in over-the-counter and prescription medications, renowned for its potent analgesic and anti-inflammatory properties. The Ibuprofen API market witnesses significant growth due to increasing demand for pain relief and inflammation management drugs. Key players in this market focus on enhancing production capacity and improving product quality to cater to the surging market needs. The market's expansion is further fueled by rising healthcare expenditures, an aging population, and a growing preference for self-medication.
Asia is forecasted to hold the largest market size by region in 2024
The Ibuprofen Active Pharmaceutical Ingredient (API) market signifies a significant business sector, characterized by robust growth and substantial demand. Ibuprofen APIs are essential components in over-the-counter and prescription medications, catering to pain relief and inflammation management. Market expansion is driven by increasing consumer awareness and preference for effective pain management solutions, coupled with technological advancements in API manufacturing processes. Businesses operating in this sector aim to capitalize on these trends, ensuring regulatory compliance and maintaining high-quality standards to meet evolving market demands.
The Ibuprofen Active Pharmaceutical Ingredient (Api) Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
Ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), is a widely used Active Pharmaceutical Ingredient (API) for treating various medical conditions, including menstrual discomfort associated with dysmenorrhea. The World Health Organization (WHO) has recognized ibuprofen's importance in healthcare, making it an essential medicine. The production of ibuprofen involves advanced techniques such as combinatorial chemistry, high-throughput methods, and bioinformatics. Top pharmaceutical manufacturers produce ibuprofen in the form of syrups, capsules, and tablets. However, the production process comes with challenges, including high manufacturing costs and environmental drawbacks. The synthetic route of ibuprofen involves several steps, which can lead to kidney damage and gastrointestinal bleeding as side effects. Biopharmaceutical companies are exploring new synthetic routes to minimize these risks. Moreover, ibuprofen is effective in treating chronic diseases such as migraine, rheumatoid arthritis, and other inflammatory conditions. The pharmaceutical industry's metamorphosis has led to the emergence of new players, particularly in emerging economies, increasing competition and driving down costs. Geriatric patients, who are more susceptible to side effects, require special considerations in the production and use of ibuprofen.
Market Research Overview
Ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), is a widely used active pharmaceutical ingredient (API) for treating various inflammatory conditions such as gout, pseudogout, lupus, psoriatic arthritis, ankylosing spondylitis, and joint inflammation associated with autoimmune diseases. Ibuprofen's analgesic properties make it effective in managing dysmenorrhea, menstrual discomfort, and other forms of pain. The production costs of ibuprofen APIs have been a topic of interest for medical producers and biopharmaceutical companies. Ibuprofen is used in the production of drugs like Duexis Tablets, which are used to treat arthritis and inflammation caused by various chronic diseases. However, the production of ibuprofen APIs comes with environmental drawbacks and potential risks, including kidney damage and gastrointestinal bleeding. The API market for ibuprofen is significant due to its wide application in various therapeutic areas, including cancer drugs, infectious diseases, and musculoskeletal disorders. The demand for ibuprofen APIs is high in healthcare environments, particularly in maternal care, geriatric patients, and pharmacy shelves. The production of ibuprofen APIs involves synthetic routes, combinatorial chemistry, high-throughput methods, and bioinformatics. The market for ibuprofen APIs is expected to grow in emerging economies due to the increasing prevalence of chronic diseases and the aging population. However, the costs and production guidelines for ibuprofen APIs remain a concern for manufacturers. The World Health Organization (WHO) has set guidelines for the safe use of NSAIDs, including ibuprofen, to minimize the risks of upper gastrointestinal ulcers and other side effects. The American Cancer Society and Statistics Canada report that ibuprofen is used to manage cancer-related pain and inflammation. Overall, the ibuprofen API market is a critical component of the pharmaceutical industry, contributing to the pharmaceutical metamorphosis and the development of new therapies.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
